Trial Search Results
Zemedy Application for Irritable Bowel Syndrome
The purpose of the study is investigate the effectiveness of Zemedy, a mobile application that enables the digital delivery of a CBT program to people with IBS.
Stanford is currently not accepting patients for this trial.
Lead Sponsor:
Stanford University
Collaborator: Bold Health Inc.
Stanford Investigator(s):
Intervention(s):
- Device: Use of Zemedy Application
Phase:
N/A
Eligibility
Inclusion Criteria:
1. Male and female patients >=18 years old.
2. Meet Rome IV criteria for IBS for at least 6 months. No restrictions on type of IBS.
3. English proficiency (in order to understand use of the application.
4. Patient must be on a stable regimen for IBS for at least 30 days.
5. Patients must own a smartphone (iOS or Android) in order to participate in the CBT
application.
Exclusion Criteria:
1. Laboratory or imaging evidence of an alternative explanation of patient's symptoms.
2. Active gastrointestinal disease such as Crohn's disease, ulcerative colitis, history
of complete colon resection, acute infection, or any disease that precludes
participation in CBT application.
3. Patient already undergoing cognitive behavioral therapy.
4. Severe anxiety or depression assessed by the HADS scale.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Brandon Lam, BS
650-725-0226